INNOVATE Corp. Portfolio Company R2 Technologies Announces Another Record-Breaking Quarter and Partnerships with Woodhouse Spas and Top Skincare Brands
R2 Technologies, a portfolio company of INNOVATE Corp. (NYSE: VATE), reported significant growth in 2024, with a 294% increase in worldwide Glacial Skin system unit sales compared to last year. The company announced new partnerships with Woodhouse Spas and leading skincare brands including Epicutis, iS CLINICAL, BABOR, and BioSkin Aesthetics. Providers using Glacial Skin systems saw a 168% increase in patients treated and a 58% increase in monthly utilization. The company's social media presence grew substantially, with a 4,086% increase in mentions during Q3.
R2 Technologies, una società del portafoglio di INNOVATE Corp. (NYSE: VATE), ha riportato una crescita significativa nel 2024, con un aumento del 294% nelle vendite globali del sistema Glacial Skin rispetto allo scorso anno. L'azienda ha annunciato nuove partnership con Woodhouse Spas e marchi di skincare leader come Epicutis, iS CLINICAL, BABOR e BioSkin Aesthetics. I fornitori che utilizzano i sistemi Glacial Skin hanno registrato un aumento del 168% nel numero di pazienti trattati e un aumento del 58% nell'utilizzo mensile. La presenza sui social media dell'azienda è cresciuta notevolmente, con un aumento del 4.086% nelle menzioni durante il terzo trimestre.
R2 Technologies, una empresa del portafolio de INNOVATE Corp. (NYSE: VATE), reportó un crecimiento significativo en 2024, con un incremento del 294% en las ventas de unidades del sistema Glacial Skin a nivel mundial en comparación con el año pasado. La compañía anunció nuevas alianzas con Woodhouse Spas y marcas de cuidado de la piel líderes, incluyendo Epicutis, iS CLINICAL, BABOR y BioSkin Aesthetics. Los proveedores que utilizan los sistemas Glacial Skin experimentaron un incremento del 168% en el número de pacientes tratados y un incremento del 58% en la utilización mensual. La presencia de la empresa en redes sociales creció sustancialmente, con un aumento del 4,086% en menciones durante el tercer trimestre.
R2 Technologies는 INNOVATE Corp. (NYSE: VATE)의 포트폴리오 회사로서, 2024년에 전 세계 Glacial Skin 시스템 판매 단위에서 294%의 유의미한 성장을 보고했습니다. 이 회사는 Woodhouse Spas 및 Epicutis, iS CLINICAL, BABOR, BioSkin Aesthetics와 같은 선도적인 스킨케어 브랜드와의 새로운 파트너십을 발표했습니다. Glacial Skin 시스템을 사용하는 의료 제공자는 치료받은 환자가 168% 증가하고 월 사용량이 58% 증가했습니다. 회사의 소셜 미디어 존재감은 상당히 증가하여, 3분기 동안 언급 횟수가 4,086% 증가했습니다.
R2 Technologies, une société du portefeuille de INNOVATE Corp. (NYSE: VATE), a signalé une croissance significative en 2024, avec une augmentation de 294% des ventes d'unités du système Glacial Skin dans le monde par rapport à l'année dernière. L'entreprise a annoncé de nouveaux partenariats avec Woodhouse Spas et des marques de soin de la peau de premier plan, y compris Epicutis, iS CLINICAL, BABOR et BioSkin Aesthetics. Les prestataires utilisant les systèmes Glacial Skin ont observé une augmentation de 168% du nombre de patients traités et une augmentation de 58% de l'utilisation mensuelle. La présence de l'entreprise sur les réseaux sociaux a considérablement augmenté, avec une augmentation de 4,086% des mentions au cours du troisième trimestre.
R2 Technologies, ein Unternehmen im Portfolio von INNOVATE Corp. (NYSE: VATE), meldete 2024 ein signifikantes Wachstum mit einem 294% Anstieg der weltweiten Verkaufszahlen des Glacial Skin Systems im Vergleich zum Vorjahr. Das Unternehmen kündigte neue Partnerschaften mit Woodhouse Spas und führenden Hautpflegemarken wie Epicutis, iS CLINICAL, BABOR und BioSkin Aesthetics an. Anbieter, die Glacial Skin Systeme verwenden, verzeichneten einen 168% Anstieg der behandelten Patienten und einen 58% Anstieg der monatlichen Nutzung. Die Präsenz des Unternehmens in den sozialen Medien wuchs erheblich, mit einem 4.086% Anstieg der Erwähnungen im dritten Quartal.
- 294% increase in worldwide Glacial Skin system unit sales year-over-year
- 168% increase in patients treated with Glacial Skin systems
- 58% increase in average monthly utilization per provider
- New partnership with Woodhouse Spas (100 locations)
- 4,086% increase in social media mentions in Q3
- None.
Insights
The record-breaking performance metrics warrant attention, with a
However, investors should note that despite impressive growth percentages, actual revenue figures and profit margins are not disclosed. Given INNOVATE Corp's small market cap of
NEW YORK, Nov. 20, 2024 (GLOBE NEWSWIRE) -- R2 Technologies, Inc., the world leader in CryoAesthetics® with its cutting-edge Glacial Skin systems (“R2”), a portfolio company of INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it has achieved several impressive milestones during 2024. The growing momentum of the brand coupled with recent key partnerships has positioned the company for substantial growth across the aesthetics and wellness sectors.
Celebrating the one-year anniversary of the Glacial fx platform launch, R2 Technologies has seen unparalleled success, recording a
With the versatility of Glacial Skin’s controlled cooling technology, the Glacial Gloss and Glacial Glide treatments can be paired with different skincare products. R2 has established partnerships and protocols with several leading skincare brands, such as Epicutis, iS CLINICAL, BABOR, and BioSkin Aesthetics. This improves the personalization and customization of the Glacial Skin offering, ultimately enhancing the client experience and allowing providers to effectively manage chronic and acute inflammation.
"Our Q2 and Q3 results are a testament to the growing demand for our innovative CryoAesthetics® solutions and the hard work of our dedicated team," said Tim Holt, CEO at R2 Technologies. "We're not just seeing growth; we're witnessing a revolution in how people approach skin health and aesthetics. We’re also incredibly excited to partner with Woodhouse Spas to bring Glacial Skin to their loyal client base, and we’re equally thrilled about our recent integration of many top skincare brands into our treatment protocols, which is a game-changing development for our existing and future Glacial Skin providers."
The Glacial Skin platforms continue to transform skin inflammation treatments into everyday clinical practice. Providers using Glacial Skin systems have seen a
R2 Technologies has further solidified its leadership position in CryoAesthetics® by introducing the Glacialist Ambassador Program. This initiative brings together a community of expert professionals dedicated to advancing the technology and best practices in CryoAesthetics®. One of the ambassadors, Candace Marino, also known as The L.A. Facialist, praised the impact of the Glacial Skin devices on both her practice and her clients:
"I've seen devices come to market year after year, but I've never seen one that benefits every skin condition and does it safely. I firmly believe that inflammation is the root cause of skin aging, and all the conditions people typically want to work on. This device has not only changed the lives of so many of my clients but has transformed my practice and the way I treat skin conditions and overall aging."
The company's efforts to expand its brand presence have also paid off. In Q3, R2 Technologies saw an astonishing 4,
As R2 Technologies heads into the final stretch of 2024, its innovative products, industry leadership, and strong partnerships position it for continued success. With groundbreaking treatments and a passionate community of professionals, R2 Technologies is setting new standards in skincare, wellness and CryoAesthetics®.
Visit glacialskin.com for more information about R2 Technologies and its innovative Glacial® Skin platforms and to find a provider near you.
About INNOVATE
INNOVATE Corp. is a portfolio of best-in-class assets in three key areas of the new economy – Infrastructure, Life Sciences and Spectrum. Dedicated to stakeholder capitalism, INNOVATE employs approximately 4,000 people across its subsidiaries. For more information, please visit: www.INNOVATECorp.com.
About R2 Technologies, Inc.
Headquartered in Silicon Valley, R2 Technologies is the world leader in CryoAesthetics® medical devices. Founded in 2014 by Pansend Life Sciences LLC, Blossom Innovations LLC, and Massachusetts General Hospital, R2 Technologies has pioneered the development of Glacial® Skin platforms for precision contact cooling of the skin, which has been shown to reduce inflammation and brighten the skin.
R2 Technologies' product lineup includes Glacial® Rx, Glacial® fx, and Glacial® Spa, with an exciting pipeline of future innovations in development. The company's strategic partnership with Huadong Medicine Co., Ltd. has further accelerated its growth and market presence.
To learn more about R2 Technologies, treatment offerings, and providers, visit glacialskin.com and follow the company on LinkedIn and Instagram.
Forward-Looking Statements
Certain statements in this press release may constitute “forward-looking statements” within the meaning of the federal securities laws. Forward-looking statements generally relate to future events, such as the expected timing of the reverse stock split, the impact of the reverse stock split on the Company’s share price, and the Company’s ability to meet the minimum per share bid price requirement for continued listing on the NYSE. You are cautioned that such statements are not guarantees of future performance and that INNOVATE’s actual results may differ materially from those set forth in the forward-looking statements. All of these forward-looking statements are subject to risks and uncertainties that may change at any time. Factors that could cause INNOVATE’s actual expectations to differ materially from these forward-looking statements include INNOVATE’s ability to continue to comply with applicable listing standards of the NYSE and the other factors under the heading “Risk Factors” set forth in INNOVATE’s Annual Report on Form 10-K, as supplemented by INNOVATE’s quarterly reports on Form 10-Q. Such filings are available on our website or at www.sec.gov. You should not place undue reliance on these forward-looking statements, which are made only as of the date of this press release. INNOVATE undertakes no obligation to publicly update or revise forward-looking statements to reflect subsequent developments, events, or circumstances, except as may be required under applicable securities laws.
Investor Contact:
Solebury Strategic Communications
Anthony Rozmus
ir@innovatecorp.com
(212) 235-2691
FAQ
What was R2 Technologies' sales growth for Glacial Skin systems in 2024?
Which major spa chain partnered with R2 Technologies in 2024?
What was the increase in patient treatments for Glacial Skin providers in 2024?
How much did R2 Technologies' social media presence grow in Q3 2024?
